Mission
Solving high-mortality disease
Solving high-mortality diseases and severe social problems with AI and smart technologies.
Company
Company
An innovative biotech company solving intractable disease and critical social challenges with AI and smart devices.
2026.05
Established
12
Patents filed (6 domestic · 6 PCT)
10+
Partner countries
1
Awards
Executive Summary
Executive Summary
Core Business
Bio AI smart glasses R&D
Bio AI smart glasses R&D, plus bio and medical device sales and trade.
Technology
AI early diagnosis & autonomy
AI-based early disease diagnosis and agents, plus drowsy-driving prevention and autonomous-driving technology.
Market
Entering convergence markets
Entering the global IVD, smart glasses and autonomous-driving convergence markets.
Partners
Partners in 10+ countries
R&D, marketing and sales collaboration with partners across 10+ countries including Korea, Japan, China, Switzerland and Singapore.
IP Status
6 domestic · 6 PCT filings
Two filings for smart glasses and autonomous driving; two each for Bio AI diagnosis and AI agents.
Company History
Company History
-
2025.05
Filed 2 domestic patents: smart glasses, AI & autonomous driving
PCT international filing completed for both
-
2025.08
Filed 4 domestic patents: Bio AI diagnosis & AI agents
PCT international filing completed for all four
-
2025.08
Marketing partnership with Shanghai Upper Bio-Tech Pharma
Channels secured across China
-
2025.09
R&D partnership with IT Lab Co., Ltd., Japan
Joint development of IVD devices and biopharmaceuticals
-
2026.02
Joint R&D partnership with CSEM SA, Switzerland
Integrating vital-sign monitoring into smart glasses
-
2026.05
GeniusMed Co., Ltd. incorporated
Headquarters established in Bundang-gu, Seongnam
-
2026.08
JoongAng Ilbo 2026 H2 Innovative IT Grand Prize
Industrial Convergence & Smart Technology category
Awards
Awards
2026.08
2026 Innovative IT Award
Hosted by the JoongAng Newspaper
Sponsored by the Institute for Information & Communications Technology Planning & Evaluation, the National IT Industry Promotion Agency and the National Information Society Agency
Awarded in the Industrial Convergence & Smart Technology category for the innovation of our Bio AI smart glasses and drowsy-driving prevention technology.
CEO Message
A company that solves problems with Bio AI technology
BL
Brian Lee
Chief Executive Officer
I launched our Bio AI, smart device and AI agent businesses in the first half of 2025, driven by our inventions in smart glasses, AI and autonomous driving.
As Meta, Samsung, Google and Apple scale up smart-glasses investment, our focus is on solving critical social problems with smart glasses and AI: preventing drowsy-driving accidents and enabling early diagnosis of severe diseases.
GeniusMed will continue to grow so that each business we have launched bears strong results.